tradingkey.logo

Kenvue rises after quarterly results beat

ReutersMay 8, 2025 11:23 AM

Shares of Tylenol maker Kenvue KVUE.N rise 4.2% to $24.08 premarket

KVUE says it earned a profit of 24 cents per share vs analysts' estimates of 23 cents per share - data compiled by LSEG

Reports Q1 revenue of $3.74 billion vs estimates of $3.67 billion

KVUE expects 2025 profit to remain flat year-over-year, anticipating higher costs from President Trump's tariffs on U.S. imports

Co had previously forecast 2025 profit to be flat to 2% growth

Separately, company appoints Amit Banati as chief financial officer, effective May 12

Up to last close, stock has risen 8.2% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI